Status:
RECRUITING
VICIS - Vienna Cirrhosis Study
Lead Sponsor:
Medical University of Vienna
Conditions:
Liver Cirrhosis
Portal Hypertension
Eligibility:
All Genders
18-100 years
Brief Summary
Patients with advanced chronic liver diseases treated at the Vienna General Hospital of the Medical University of Vienna will be offered to participate in this prospective observational trial - includ...
Detailed Description
Patients with advanced chronic liver disease (ACLD) as evident by HVPG\>5mmHg or liver biopsy showing F3/F4 fibrosis or as suggested by liver stiffness measurement (LSM) ≥10kPa can be included in the ...
Eligibility Criteria
Inclusion
- Age \>18 years and \<100 years
- Diagnosis of advanced chronic liver disease (by liver stiffness ≥10kPa, HVPG\>5mmHg or Histology F3/F4)
- Written informed consent
Exclusion
- Withdrawal of written informed consent
Key Trial Info
Start Date :
February 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT03267615
Start Date
February 1 2017
End Date
December 31 2027
Last Update
September 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Austria, 1090